Sr. VP Mktg & Clinical Affairs
Avg Cost/Share
$28.94
Shares
6,246
Total Value
$180,764.24
Owned After
82,581
SEC Form 4
Sr. VP Mktg & Clinical Affairs
Avg Cost/Share
$28.49
Shares
4,439
Total Value
$125,611.96
Owned After
82,581
Sr. VP Mktg & Clinical Affairs
Avg Cost/Share
$28.85
Shares
5,139
Total Value
$148,260.15
Owned After
82,581
SEC Form 4
Sr. VP Mktg & Clinical Affairs
Avg Cost/Share
$14.40
Shares
6,468
Total Value
$93,159.90
Owned After
82,581
SEC Form 4
Sr. VP Mktg & Clinical Affairs
Avg Cost/Share
$14.65
Shares
4,830
Total Value
$70,752.74
Owned After
82,581
SEC Form 4
Sr. VP Mktg & Clinical Affairs
Avg Cost/Share
$14.37
Shares
815
Total Value
$11,712.77
Owned After
82,581
SEC Form 4
Sr. VP Mktg & Clinical Affairs
Avg Cost/Share
$15.42
Shares
1,334
Total Value
$20,707.03
Owned After
82,581
Sr. VP Mktg & Clinical Affairs
Avg Cost/Share
$15.35
Shares
4,264
Total Value
$65,326.58
Owned After
82,581
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Feb 24, 2026 | Sell | $28.94 | 6,246 | $180,764.24 | 82,581 | |
| Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Feb 23, 2026 | Sell | $28.49 | 4,439 | $125,611.96 | 82,581 | |
| Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Jan 2, 2026 | Sell | $28.85 | 5,139 | $148,260.15 | 82,581 | |
| Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Feb 25, 2025 | Sell | $14.40 | 6,468 | $93,159.90 | 82,581 | |
| Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Feb 20, 2025 | Sell | $14.65 | 4,830 | $70,752.74 | 82,581 | |
| Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | May 6, 2024 | Sell | $14.37 | 815 | $11,712.77 | 82,581 | |
| Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Feb 27, 2024 | Sell | $15.42 | 1,334 | $20,707.03 | 82,581 | |
| Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Feb 23, 2024 | Sell | $15.35 | 4,264 | $65,326.58 | 82,581 |